Forian Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023
March 28, 2024 at 04:21 pm EDT
Share
Forian Inc. reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was USD 5.37 million compared to USD 4.97 million a year ago. Net income was USD 1.39 million compared to net loss of USD 3.56 million a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.06 a year ago. Diluted loss per share from continuing operations was USD 0.01 compared to USD 0.06 a year ago. Basic earnings per share was USD 0.04 compared to basic loss per share of USD 0.11 a year ago. Diluted earnings per share was USD 0.04 compared to diluted loss per share of USD 0.11 a year ago.
For the full year, sales was USD 20.48 million compared to USD 16.42 million a year ago. Net income was USD 11.11 million compared to net loss of USD 25.97 million a year ago. Basic earnings per share from continuing operations was USD 0.05 compared to basic loss per share from continuing operations of USD 0.6 a year ago. Diluted earnings per share from continuing operations was USD 0.05 compared to diluted loss per share from continuing operations of USD 0.6 a year ago. Basic earnings per share was USD 0.34 compared to basic loss per share of USD 0.81 a year ago. Diluted earnings per share was USD 0.34 compared to diluted loss per share of USD 0.81 a year ago.
Forian Inc. is a technology solutions company. The Company provides a suite of data management capabilities and data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer and provider segments. The Companyâs operations consist of providing analytic and information services to the healthcare and related industries, which are all subscription and services-based solutions. The Companyâs offerings include commercial, Real World Evidence (RWE) and market access solutions and data-driven insights to optimize the operational, clinical and financial performance of its customers. The Company provides its information solutions both as an enabling technology to consultants and service providers serving the healthcare and life sciences industries, as well as to end users in the healthcare and life sciences industries.